FindTrial
Sign In

Effect of Euphorbia fischeriana Steud cataplasmata for cervical lymphadenopathy

Effect of Euphorbia fischeriana Steud cataplasmata for cervical lymphadenopathy

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-TRC-11001293
Enrollment
Unknown
Registered
2011-01-15
Start date
2011-05-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

cervical lymphadenopathy

Interventions

Group A:antituberculosis + apply Euphorbia fischeriana Steud cataplasmata,1 year
Group B:antituberculosis,1 year

Sponsors

Hangzhou Red Cross Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. consistent with diagnostic criteria of cervical lymphadenopathy; 2. non- pregnant woman; 3. Patients without other organ severe disease, sush as cardia, liver, kidney, without lithicosis, diabetes, psychiatric history; 4. patients without immune disease as human immunodeficiency virus, beriberoid disease, rheumatoid, etc.

Exclusion criteria

Exclusion criteria: 1. other non-tuberculosis lymphadenectasis disease as La Verruga diseas, or Kawasaki disease; 2. cervical lymphadenopathy with other disease can cause lymphadenectasis as lymphoma.

Design outcomes

Primary

MeasureTime frame
interleukin 12;CD4+ T cells;CD8+ T cells;interferon g;—

Countries

China

Contacts

Public ContactMin Zhu
zhumindoctor@yahoo.cn+86 13958107682

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026